John L Higgins, Ligand Pharmaceuticals Incorporated's Chief Executive Officer and a director of the company, recently acquired 2,500 shares of the company. The buys took place at $113.50 per share, on May 14, 2019. Higgins now owns 143,899 shares of the company. Higgins operates out of San Diego, CA.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!
Other recent filings from the company include the following: